Company research / VASO

Vaso Corp (VASO)

SEC name VASO Corp · CIK 0000839087 · OTC · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, Vaso Corp reported revenue of $89.10M. Revenue grew 2.7% from the prior annual period.

Key ratios (year ended 2025-12-31)

61.4%
Gross margin
-3.2%
Operating margin
1.8%
Net margin
5.3%
Return on year-end equity
2.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenuen/a$89.10M$86.77M$81.02M$79.29M$75.58M$69.85M$75.52M$73.98M$72.79M$72.59M
Cost of Revenuen/a$34.42M$34.72M$30.43M$31.39Mn/an/an/an/an/an/a
Gross Profitn/a$54.67M$52.05M$50.59M$47.90M$43.13M$38.57M$42.43M$41.12M$40.73M$41.50M
R&D Expense$778.0K$728.0K$851.0K$755.0K$605.0K$1.72M$745.0K$813.0K$886.0K$945.0K$530.0K
Operating Incomen/a-$2.89M$285.0K$4.20M$6.45M$2.82M$772.0K$591.0K-$3.72M-$3.83M$1.56M
Depreciation & Amortization$978.0K$858.0K$824.0K$999.0K$1.92M$3.84M$2.46M$2.68M$2.52M$2.43M$2.16M
EBITDAn/a-$2.03M$1.11M$5.19M$8.38M$6.66M$3.23M$3.27M-$1.20M-$1.41M$3.72M
Net Income$2.50M$1.57M$951.0K$4.80M$11.29M$6.10M$358.0K-$382.0K-$3.73M-$4.54M$820.0K
EPS (Diluted)n/a$0.01$0.01$0.03$0.06n/a$0.00$0.00-$0.02n/an/a
Total Assets$85.91M$88.35M$82.94M$75.76M$71.64M$52.36M$50.38M$54.36M$50.47M$56.78M$57.38M
Long-Term Debtn/an/an/an/a$15.0K$23.0K$5.78Mn/a$10.54M$8.90M$9.57M
Shareholders' Equity$29.21M$29.43M$27.70M$26.84M$22.07M$11.31M$5.08M$4.31M$5.61M$9.15M$12.91M
Cash & Equivalents$38.29M$35.05M$26.27M$11.34M$11.82M$6.03M$6.82M$2.12M$2.67M$5.25M$7.09M
Operating Cash Flow$7.86M$9.27M$3.28M$5.30M$14.42M$7.82M$5.93M-$1.33M-$1.45M$1.60M$5.21M
Capital Expendituresn/an/an/an/a$566.0K$415.0K$1.00M$1.21M$2.59M$2.37M$1.87M
Free Cash Flown/an/an/an/a$13.85M$7.40M$4.93M-$2.54M-$4.04M-$775.0K$3.35M
Shares Outstanding176.02M175.95M175.70M175.32M175.13M175.13Mn/an/an/a165.43M163.50M
Weighted Average Diluted Sharesn/a176.00M175.59M175.54M174.66M173.77M170.8K167.8K165.4K162.21M159.40M
EPS (Basic)n/a$0.01$0.01$0.03$0.07$0.04$0.00$0.00-$0.02n/an/a